Ingrid Cabrera Puig

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial

Iman Satti, Julia L. Marshall, Stephanie A. Harris et al. · The Lancet Infectious Diseases · 2024 · 28 citations · Full text

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

Susan Jackson, Julia L. Marshall, Andrew Mawer et al. · The Lancet Microbe · 2024 · 20 citations · Full text

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial

Anne Wajja, Beatrice Nassanga, Agnes Natukunda et al. · The Lancet Infectious Diseases · 2023 · 17 citations · Full text